Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026)
Zimmer Biomet Holdings (ZBH) recorded quarterly Other Non-Current Liabilities of $630.7 million in Q1 2026, up 0.73% quarter-over-quarter from $626.1 million in Q4 2025, and up 358.02% on a YoY basis from $137.7 million in Q1 2025.
Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $630.7 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 358.02% year-over-year to $630.7 million; the TTM figure through Mar 2026 stood at $630.7 million (up 358.02% YoY), while the FY2025 annual figure was $626.1 million, up 246.49% from the prior year.
- Other Non-Current Liabilities was $630.7 million for Q1 2026 at Zimmer Biomet Holdings, up from $626.1 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.2 billion in Q2 2024 to a low of $137.7 million in Q1 2025.
- Historically, Other Non-Current Liabilities has averaged $665.1 million across 5 years, with a median of $631.9 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Other Non-Current Liabilities plunged 80.48% in 2024, then soared 358.02% in 2026.
- A 5-year view of Other Non-Current Liabilities shows it stood at $632.6 million in 2022, then jumped by 46.35% to $925.8 million in 2023, then slumped by 80.48% to $180.7 million in 2024, then surged by 246.49% to $626.1 million in 2025, then climbed by 0.73% to $630.7 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $630.7 million (Q1 2026), $626.1 million (Q4 2025), and $806.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630.70 Mn |
| Dec 31, 2025 | 626.10 Mn |
| Sep 30, 2025 | 806.40 Mn |
| Jun 30, 2025 | 878.80 Mn |
| Mar 31, 2025 | 137.70 Mn |
| Dec 31, 2024 | 180.70 Mn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 577.00 Mn |
| Dec 31, 2023 | 925.80 Mn |
| Sep 30, 2023 | 631.90 Mn |
| Jun 30, 2023 | 642.00 Mn |
| Mar 31, 2023 | 637.40 Mn |
| Dec 31, 2022 | 632.60 Mn |
| Sep 30, 2022 | 581.30 Mn |
| Jun 30, 2022 | 591.00 Mn |
| Mar 31, 2022 | 593.10 Mn |
| Dec 31, 2021 | 548.50 Mn |
| Sep 30, 2021 | 606.70 Mn |
| Jun 30, 2021 | 581.60 Mn |